TB22
TB22 is a non-nucleoside inhibitor of DOT1LR231Q, possessing anticancer activity. TB22 inhibits the malignant phenotype of lung cancer cells carrying the R231Q mutation through the MAPK/ERK signaling pathway, and can be used for lung cancer research[1].
Product Specifications
UNSPSC
12352211
Target
Histone Methyltransferase
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/tb22.html
Smiles
CC(C1=CC=C(C=C1)NC(NCCCN(CCCN2CCOCC2)CC3(O)CN(CC3)C4=NC(Cl)=NC5=C4C=CS5)=O)(C)C
Molecular Formula
C32H46ClN7O3S
Molecular Weight
644.27
References & Citations
[1]Tan Z, et al. Discovery of Novel Non-nucleoside DOT1LR231Q Inhibitors with Improved Pharmacokinetic Properties and Anti-lung Cancer Efficacy[J]. Journal of Medicinal Chemistry, 2024.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
H2649 96 Tests
Sperm-associated antigen 4 protein (SPAG4) Mouse ELISA Kit
Sign In for Pricing
View Details 
NBP3-20813C 0.1 mL
Mouse Monoclonal BCMA/TNFRSF17 Antibody (rCD269/8507) [DyLight 650]
Sign In for Pricing
View Details 
20294121 3x 1.0µg DNA
FBXL17 CRISPRa sgRNA lentivector (set of three targets)(Human)
Sign In for Pricing
View Details